PROVECTUS BIOPHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,070 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 526-550 of 796 matching filings.

Per page
25
Current page
22
8-K File 001-36457

FORM 8-K

Filing date
30 Apr 2015
Reporting date
30 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
29 Apr 2015
Reporting date
29 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
27 Apr 2015
Reporting date
27 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
20 Apr 2015
Reporting date
20 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
15 Apr 2015
Reporting date
15 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
08 Apr 2015
Reporting date
08 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
07 Apr 2015
Reporting date
07 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
02 Apr 2015
Reporting date
02 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
20 Mar 2015
Reporting date
20 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36457

8-K/A

Filing date
16 Mar 2015
Reporting date
16 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
16 Mar 2015
Reporting date
16 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
12 Mar 2015
Reporting date
12 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
24 Feb 2015
Reporting date
24 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
18 Feb 2015
Reporting date
18 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
10 Feb 2015
Reporting date
10 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
09 Feb 2015
Reporting date
09 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
06 Feb 2015
Reporting date
06 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
29 Jan 2015
Reporting date
29 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Jan 2015
Reporting date
24 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
26 Jan 2015
Reporting date
26 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jan 2015
Reporting date
07 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jan 2015
Reporting date
07 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
02 Jan 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Dec 2014
Reporting date
30 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .